UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Weis Markets
WMK
$1.75B
| $1.59M | ﹤0.01% |
20,359
-164
| -0.8% | -$12K |
|
2127
Collegium Pharmaceutical
COLL
$852M
| $1.59M | ﹤0.01% |
44,011
-8,181
| -16% | -$280K |
|
2128
F&G Annuities & Life
FG
$3.02B
| $1.59M | ﹤0.01% |
59,860
-6,001
| -9% | -$164K |
|
2129
Kimbell Royalty Partners
KRP
$1.53B
| $1.59M | ﹤0.01% |
+109,441
| New | +$1.63M |
|
|
SKYT
2130
DELISTED
SkyWater Technology
SKYT
| $1.59M | ﹤0.01% |
45,530
+4,893
| +12% | +$167K |
|
2131
Monte Rosa Therapeutics
GLUE
$1.24B
| $1.58M | ﹤0.01% |
65,451
+46,172
| +239% | +$872K |
|
2132
Polestar Automotive Holding UK
PSNY
$1.82B
| $1.58M | ﹤0.01% |
84,151
+34,295
| +69% | +$685K |
|
2133
AnaptysBio
ANAB
$1.73B
| $1.57M | ﹤0.01% |
23,310
-7,417
| -24% | -$450K |
|
2134
Wipro
WIT
$18.6B
| $1.57M | ﹤0.01% |
698,564
+79,000
| +13% | +$168K |
|
2135
SunCoke Energy
SXC
$828M
| $1.57M | ﹤0.01% |
194,569
-2,226
| -1% | -$17.2K |
|
2136
PC Connection
CNXN
$2B
| $1.56M | ﹤0.01% |
21,358
-460
| -2% | -$30.7K |
|
2137
Phibro Animal Health
PAHC
$1.46B
| $1.56M | ﹤0.01% |
49,595
-581
| -1% | -$24.5K |
|
2138
Melco Resorts & Entertainment
MLCO
$2.08B
| $1.56M | ﹤0.01% |
295,399
-13,942
| -5% | -$77.9K |
|
2139
Capital Group Short Duration Municipal Income ETF
CGSM
$1.58B
| $1.55M | ﹤0.01% |
58,750
| – | – |
|
|
ADAM
2140
Adamas Trust
ADAM
$884M
| $1.54M | ﹤0.01% |
164,521
-3,156
| -2% | -$27.1K |
|
2141
Vanguard Information Technology ETF
VGT
$144B
| $1.54M | ﹤0.01% |
12,894
-146,722
| -92% | -$16.1M |
|
2142
Castle Biosciences
CSTL
$1.07B
| $1.53M | ﹤0.01% |
64,346
-618
| -1% | -$13.8K |
|
2143
Standard Motor Products
SMP
$838M
| $1.53M | ﹤0.01% |
39,375
-567
| -1% | -$21.7K |
|
2144
Cullinan Oncology
CGEM
$1.48B
| $1.53M | ﹤0.01% |
84,178
+16,522
| +24% | +$245K |
|
2145
Rush Enterprises Class B
RUSHB
$8.44B
| $1.53M | ﹤0.01% |
20,028
+1,172
| +6% | +$81.7K |
|
|
NTSK
2146
Netskope Inc
NTSK
$5.45B
| $1.53M | ﹤0.01% |
140,022
+111,722
| +395% | +$1.14M |
|
2147
US Physical Therapy
USPH
$1.15B
| $1.53M | ﹤0.01% |
22,283
-3,049
| -12% | -$207K |
|
2148
Appian
APPN
$2.84B
| $1.52M | ﹤0.01% |
66,579
-19,421
| -23% | -$432K |
|
2149
Invesco
IVZ
$14.4B
| $1.52M | ﹤0.01% |
57,770
-947,631
| -94% | -$25.1M |
|
2150
Energy Recovery
ERII
$401M
| $1.52M | ﹤0.01% |
169,005
+3,297
| +2% | +$31.3K |
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.